146 related articles for article (PubMed ID: 38313355)
1. The effects of N-acetylcysteine on hepatic, hematologic, and renal parameters in cirrhotic patients: a randomized controlled trial.
Hatami B; Abdi S; Pourhoseingholi MA; Eghlimi H; Rabbani AH; Masoumi M; Hajimohammadebrahim-Ketabforoush M
Gastroenterol Hepatol Bed Bench; 2023; 16(4):432-440. PubMed ID: 38313355
[TBL] [Abstract][Full Text] [Related]
2. A study to evaluate the hepatoprotective effect of N- acetylcysteine on anti tuberculosis drug induced hepatotoxicity and quality of life.
Sukumaran D; Usharani P; Paramjyothi GK; Subbalaxmi MVS; Sireesha K; Abid Ali M
Indian J Tuberc; 2023 Jul; 70(3):303-310. PubMed ID: 37562904
[TBL] [Abstract][Full Text] [Related]
3. Effects of low dose zinc supplementation on biochemical markers in non-alcoholic cirrhosis: a randomized clinical trial.
Somi MH; Rezaeifar P; Ostad Rahimi A; Moshrefi B
Arch Iran Med; 2012 Aug; 15(8):472-6. PubMed ID: 22827782
[TBL] [Abstract][Full Text] [Related]
4. Effect of N-acetylcysteine on serum creatinine and kidney function: results of a randomized controlled trial.
Moist L; Sontrop JM; Gallo K; Mainra R; Cutler M; Freeman D; House AA
Am J Kidney Dis; 2010 Oct; 56(4):643-50. PubMed ID: 20541301
[TBL] [Abstract][Full Text] [Related]
5. N-acetylcysteine does not prevent hepatorenal ischaemia-reperfusion injury in patients undergoing orthotopic liver transplantation.
Hilmi IA; Peng Z; Planinsic RM; Damian D; Dai F; Tyurina YY; Kagan VE; Kellum JA
Nephrol Dial Transplant; 2010 Jul; 25(7):2328-33. PubMed ID: 20179007
[TBL] [Abstract][Full Text] [Related]
6. Double-blind placebo-controlled randomized trial of N-acetylcysteine infusion following live donor liver transplantation.
Thirunavayakalathil MA; Varghese CT; Bharathan VK; Chandran B; Nair K; Mallick S; Mathew JS; Amma BSPT; Menon RN; Gopalakrishnan U; Balakrishnan D; Sudheer OV; Surendran S
Hepatol Int; 2020 Dec; 14(6):1075-1082. PubMed ID: 33278022
[TBL] [Abstract][Full Text] [Related]
7. N-acetylcysteine protects against diabetic nephropathy through control of oxidative and nitrosative stress by recovery of nitric oxide in rats.
Nogueira GB; Punaro GR; Oliveira CS; Maciel FR; Fernandes TO; Lima DY; Rodrigues AM; Mouro MG; Araujo SRR; Higa EMS
Nitric Oxide; 2018 Aug; 78():22-31. PubMed ID: 29778909
[TBL] [Abstract][Full Text] [Related]
8. Hepatic cirrhosis increases sensitivity of kidney to endotoxin in rats.
Liu JJ; Wang JY; Zhang C; Nilsson A; Duan RD
Med Sci Monit; 2002 Feb; 8(2):BR56-60. PubMed ID: 11862160
[TBL] [Abstract][Full Text] [Related]
9. Antioxidant supplementation for lung disease in cystic fibrosis.
Ciofu O; Smith S; Lykkesfeldt J
Cochrane Database Syst Rev; 2019 Oct; 10(10):CD007020. PubMed ID: 31580490
[TBL] [Abstract][Full Text] [Related]
10. Effects of N-acetylcysteine supplementation on disease activity, oxidative stress, and inflammatory and metabolic parameters in rheumatoid arthritis patients: a randomized double-blind placebo-controlled trial.
Esalatmanesh K; Jamali A; Esalatmanesh R; Soleimani Z; Khabbazi A; Malek Mahdavi A
Amino Acids; 2022 Mar; 54(3):433-440. PubMed ID: 35133468
[TBL] [Abstract][Full Text] [Related]
11. Effect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency: a randomized trial.
Fung JW; Szeto CC; Chan WW; Kum LC; Chan AK; Wong JT; Wu EB; Yip GW; Chan JY; Yu CM; Woo KS; Sanderson JE
Am J Kidney Dis; 2004 May; 43(5):801-8. PubMed ID: 15112170
[TBL] [Abstract][Full Text] [Related]
12. The model for the end-stage liver disease and Child-Pugh score in predicting prognosis in patients with liver cirrhosis and esophageal variceal bleeding.
Benedeto-Stojanov D; Nagorni A; Bjelaković G; Stojanov D; Mladenović B; Djenić N
Vojnosanit Pregl; 2009 Sep; 66(9):724-8. PubMed ID: 19877551
[TBL] [Abstract][Full Text] [Related]
13. Effect of N-acetyl cysteine (NAC), an organosulfur compound from Allium plants, on experimentally induced hepatic prefibrogenic events in Wistar rat.
Nissar AU; Farrukh MR; Kaiser PJ; Rafiq RA; Afnan Q; Bhushan S; Adil HS; Subhash BC; Tasduq SA
Phytomedicine; 2013 Jul; 20(10):828-33. PubMed ID: 23578993
[TBL] [Abstract][Full Text] [Related]
14. The effect of short-term, high-dose oral N-acetylcysteine treatment on oxidative stress markers in cystic fibrosis patients with chronic P. aeruginosa infection -- a pilot study.
Skov M; Pressler T; Lykkesfeldt J; Poulsen HE; Jensen PØ; Johansen HK; Qvist T; Kræmer D; Høiby N; Ciofu O
J Cyst Fibros; 2015 Mar; 14(2):211-8. PubMed ID: 25458464
[TBL] [Abstract][Full Text] [Related]
15. Does Short-Term and Low-Dose N-Acetylcysteine Affect Oxidative Stress and Inflammation in The Liver Tissues of Diabetic Rats?
Genç F; Peker EGG
Biol Res Nurs; 2021 Oct; 23(4):568-574. PubMed ID: 33739173
[TBL] [Abstract][Full Text] [Related]
16. The effect of N-acetylcysteine on renal function, nitric oxide, and oxidative stress after angiography.
Efrati S; Dishy V; Averbukh M; Blatt A; Krakover R; Weisgarten J; Morrow JD; Stein MC; Golik A
Kidney Int; 2003 Dec; 64(6):2182-7. PubMed ID: 14633141
[TBL] [Abstract][Full Text] [Related]
17. Emricasan Improves Liver Function in Patients With Cirrhosis and High Model for End-Stage Liver Disease Scores Compared With Placebo.
Frenette CT; Morelli G; Shiffman ML; Frederick RT; Rubin RA; Fallon MB; Cheng JT; Cave M; Khaderi SA; Massoud O; Pyrsopoulos N; Park JS; Robinson JM; Yamashita M; Spada AP; Chan JL; Hagerty DT
Clin Gastroenterol Hepatol; 2019 Mar; 17(4):774-783.e4. PubMed ID: 29913280
[TBL] [Abstract][Full Text] [Related]
18. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
[TBL] [Abstract][Full Text] [Related]
19. Effect of curcumin supplementation on disease severity in patients with liver cirrhosis: A randomized controlled trial.
Nouri-Vaskeh M; Malek Mahdavi A; Afshan H; Alizadeh L; Zarei M
Phytother Res; 2020 Jun; 34(6):1446-1454. PubMed ID: 32017253
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
